These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 405803)

  • 21. [Prevention of sensitization of Rh-negative mothers following birth of a Rh-positive child and blood group serological control of mothers during pregnancy].
    Schneider J; Preisler O
    Hippokrates; 1968 Mar; 39(5):165-70. PubMed ID: 4978254
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current trends in immunoprophylaxis of anti-Rho isoimmunization].
    Sirchia G; Mercuriali F
    Clin Ter; 1970 Feb; 52(4):385-90. PubMed ID: 5005934
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of the effectiveness of anti Rh gamma globulin].
    García Roel R; Santos Martínez A; Salgado Alcocer N
    Ginecol Obstet Mex; 1974 Jan; 35(207):67-73. PubMed ID: 4133289
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 25. [Materno-fetal Rh-factor isoimmunization without hemolytic disease].
    Di Palma L; Carcano G; Manzi F
    Pediatria (Napoli); 1975 Jun; 83(2):317-25. PubMed ID: 809742
    [No Abstract]   [Full Text] [Related]  

  • 26. Sensitization of Rh-negative daughters by their Rh-positive mothers.
    Taylor JF
    N Engl J Med; 1967 Mar; 276(10):547-51. PubMed ID: 4960066
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anti-D isoimmunization: cases at the L. Mangiagalli Obstetrical and Gynecological Clinic I from June 1974 to December 1978. Perinatal results].
    Brambati B; Zuliani G; Regalia AL; Pardi G; Chierichetti G; Dambrosio F; Caccamo ML
    Ann Ostet Ginecol Med Perinat; 1980; 101(4):225-34. PubMed ID: 6787970
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevention of fetomaternal immunizations].
    Mahon R; Moulinier J; Dubecq JP; Lepage F; Ravina JH; Landeau MC
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1():Suppl 1:3-50. PubMed ID: 4634195
    [No Abstract]   [Full Text] [Related]  

  • 29. [Maternal anti-Rh isoimmunization and fetal erythroblastosis in the Clinica Ostetrica e Ginecologica of the University of Perugia in the 15-year-period 1962-66].
    Di Stefano M
    Arch Ostet Ginecol; 1967; 72(6):780-802. PubMed ID: 4974764
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prediction of fetal damage in anti-RH isoimmunization. 2 statistical approaches].
    Feinerman D; Rabarison Y; Rumeau-Rouquette C; Roux F; Boreau T
    J Gynecol Obstet Biol Reprod (Paris); 1973; 2(8):1029-40. PubMed ID: 4220040
    [No Abstract]   [Full Text] [Related]  

  • 31. [Several problems of pregnancy complicated by blood group incompatibility].
    Noda K
    Nihon Hoigaku Zasshi; 1968 Jul; 22(4):339-50. PubMed ID: 4973992
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hemolytic disease of the newborn due to incompatibility of the Rhc subgroup].
    Marks-Zakrzewska A; Helińska C
    Pediatr Pol; 1969 Oct; 44(11):1429-31. PubMed ID: 4982570
    [No Abstract]   [Full Text] [Related]  

  • 33. [Incidence of irregular antibodies found in patients and in pregnancy tests].
    Busch H; Rothe B von E; Hochweller E
    Munch Med Wochenschr; 1970 Feb; 112(8):341-51. PubMed ID: 4997704
    [No Abstract]   [Full Text] [Related]  

  • 34. Future trends in antepartum assessment of the Rh problem.
    Queenan JT
    Ann Ostet Ginecol Med Perinat; 1970 Aug-1971 Aug; 92(8):469-72. PubMed ID: 5001768
    [No Abstract]   [Full Text] [Related]  

  • 35. [On immunosuppressive agents in heterospecific pregnancies].
    Brigato G; Ilacqua N; Broglio L; Marigo A
    Minerva Ginecol; 1970 Nov; 22(21):1064-9. PubMed ID: 4995756
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemolytic disease of the newborn caused by fetomaternal incompatibility].
    Escandé CA; Lorenzo y de Ibarreta J; Temesio N; Garófalo O; Pérez-Scremini A; Vila-Vidal P; Vilanova R
    Arch Pediatr Urug; 1965 Jul; 36(7):455-68. PubMed ID: 4954973
    [No Abstract]   [Full Text] [Related]  

  • 37. [New information about the prevention of Rh isoimmunization].
    Tesauro G
    Minerva Ginecol; 1968 May; 20(10):847-50. PubMed ID: 4186920
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anti-D prevention. Review and outlook for 1976].
    Schneider J
    Fortschr Med; 1976 Nov; 94(31):1747-52. PubMed ID: 826466
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasmapheresis in Rh immunized pregnant women.
    Simonovits I; Vedrödi K; Jókuti I; Forgács J; Gy S
    Acta Haematol Pol; 1981; 12(2):65-7. PubMed ID: 6795880
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.